News
News
Academy
Multimedia
Editorial PodcastsEditorial VideosPeer ExchangeProfiles in Medicine
Conferences
Conference CoverageConference Listing
More
Publications
Pharmaceutical Executive
Partner Perspectives
Resources
Content Engagement HubsE-BooksEventsSponsored PodcastsSponsored VideosWebcastsWhitepapers

Subscribe

  • News
  • Academy
  • Multimedia
  • Conferences
  • Publications
  • Partner Perspectives
  • Resources
  • Subscribe
  • Corporate Communications
    • Press Releases
    • Executive Roundtable
    • Executive Profiles
    • Leadership
  • Direct-to-Consumer
    • Patient Education
    • Healthcare Access
    • Telehealth
  • Emerging Biopharma
    • Partnerships
    • Funding
  • IR Licensing and Partnerships
    • Finance
    • Industry Trends
  • Market Access
    • Patient Access
    • Pricing
    • Strategy
  • Medical Affairs
    • Patient Advocacy
    • Clinical Data
    • Pharmacovigilance
  • Operations
    • Sustainability
    • Technology
    • R&D/Clinical Trials
    • Supply Chain
  • Patient Engagement
    • DE&I
  • Regulatory
    • FDA
    • Legal
    • Global
  • Sales & Marketing
    • Sales Effectiveness
    • Campaigns
    • DTC Marketing
    • Medical Education
Spotlight -
Latest Executive Roundtables|
Asembia 2025 |
Sales Effectiveness
Advertisement

Brian Mahoney

Advertisement

Articles by Brian Mahoney

Opening Digital Doors: Remote Selling During COVID-19

ByMark McLaughlin,Brian Mahoney
December 11th 2020

Adoption of digital by biopharma reps has added an element of flexibility to their engagement strategies, resulting in better communications with HCPs.

Advertisement

Latest Updated Articles

  • Opening Digital Doors: Remote Selling During COVID-19
    Opening Digital Doors: Remote Selling During COVID-19

    Published: December 11th 2020 | Updated:



Advertisement
Advertisement

Trending on PharmExec

1

Eli Lilly Announces New $3.5 Billion Manufacturing Facility in Pennsylvania

2

FDA Rejects AstraZeneca’s Application for Subcutaneous Indication of Saphnelo

3

From OR to Office: How Workflow Change and AI Are Reshaping MedTech Adoption

4

ACIP Member Claims FDA Commissioner is Halting Decision to Remove Covid Vaccines from the Market: Report

5

Pharmaceutical Executive Daily: SanegeneBio's $1.5 Billion License Agreement with Genentech

  • About
  • Advertise
  • Contact Us
  • Editorial Board
  • Editorial Submission Guidelines
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us